Management of Stable Angina with Ivabradine as Safe Alternative to Patients with Myasthenia Gravis

Management of cardiac symptoms in myasthenia gravis (MG) patients can be challenging. The aim of this report is to describe the safe use of ivabradine for stable angina in MG patients. A 48 y.o. woman, with MG diagnosis, presented stable angina. Therapies choices were reduced considering concomitant...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohde Dalledone, Giuliano, Lenci Marques, Gustavo, Dal-Prá Ducci, Renata, Laffitte Stier Junior, Arnaldo, Kay, Cláudia Suemi Kamoi, Cesar Werneck, Lineu, José Lorenzoni, Paulo, Herminia Scola, Rosana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086353/
https://www.ncbi.nlm.nih.gov/pubmed/27822397
http://dx.doi.org/10.1155/2016/3589204
Descripción
Sumario:Management of cardiac symptoms in myasthenia gravis (MG) patients can be challenging. The aim of this report is to describe the safe use of ivabradine for stable angina in MG patients. A 48 y.o. woman, with MG diagnosis, presented stable angina. Therapies choices were reduced considering concomitant disease as well as previous and unsuccessful cardiologic managements. Ivabradine showed unexpected results. The patient presented an improvement of neurological and cardiac symptoms, bringing ivabradine as one more therapeutic option to similar patients. In this report we recommend ivabradine as an effective and safe drug for treatment of stable angina in MG patients.

Ejemplares similares